Anti-F. tularensis LVS Lipopolysaccharide (LPS) [12] Antibody
Invented at Stony Brook University
- Datasheet
- References (2)
- Inventor Info
Info
![Image for Anti-F. tularensis LVS Lipopolysaccharide (LPS) [12] Antibody](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,q_auto/bd13ba25-79cc-44df-810c-307e66cf753f.png)
![Image for Anti-F. tularensis LVS Lipopolysaccharide (LPS) [12] Antibody](https://res.cloudinary.com/ximbio/image/upload/c_limit,fl_lossy,h_282,q_auto,w_368/bd13ba25-79cc-44df-810c-307e66cf753f.png)
![Image thumbnail for Anti-F. tularensis LVS Lipopolysaccharide (LPS) [12] Antibody](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/bd13ba25-79cc-44df-810c-307e66cf753f.png)
| Catalogue Number | 154039 |
| Applications | ELISA IF IP WB |
| Antigen/Gene or Protein Targets | Lipopolysaccharide (LPS) |
| Reactivity | Francisella tularensis |
| Relevance | This mouse IgG2a monoclonal antibody is reactive against both F. tularensis LVS and F. tularensis SchuS4 protein Lipopolysaccharide (LPS) (does not react with F. novicida). Francisella tularensis is a small pathogenic gram-negative bacterium that causes tularemia. |
| Host | Mouse |
| Immunogen | Sublethal infection with F. tularensis LVS |
| Subclass | IgG2a |
| Research Area | Bacteriology |
References: 2 entries
Savitt et al. 2009. Clin Vaccine Immunol. 16(3):414-22. PMID: 19176692.
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
Europe PMC ID: 19176692
Add a reference
References: 2 entries
Savitt et al. 2009. Clin Vaccine Immunol. 16(3):414-22. PMID: 19176692.
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
Add a reference
